Is Sonoma Pharmaceuticals (SNOA) stock Halal?

Sonoma Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing healing solutions for dermatological conditions and advanced wound care. The primary purpose of this entity is to create non-toxic therapies that safely reduce infections and inflammation, accelerating the body's natural healing processes. Its product portfolio includes a range of topical anti-infective treatments and skin care solutions tailored for various fields, including dermatology, wound care, eye care, and animal health. Before any of that matters to a Muslim investor, one question comes first: is Sonoma Pharmaceuticals stock Halal?

Is Sonoma Pharmaceuticals Shariah compliant?

No. In the October 2026 screening Sonoma Pharmaceuticals (SNOA) does not pass AAOIFI screening: it fails the interest-bearing investments screen. Healthcare rarely troubles the activity screen; treating illness is permissible work. For Sonoma Pharmaceuticals, the AAOIFI Shariah Standard No. 21 verdict turns on the balance sheet instead: research is capital hungry, and interest bearing debt and investments must each stay below 30% of market capitalisation.

Does Sonoma Pharmaceuticals pass the business activity test?

The activity screen is only part of the picture this month: Sonoma Pharmaceuticals currently fails the interest-bearing investments screen, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.

Is Sonoma Pharmaceuticals' income Halal?

Yes, within AAOIFI's tolerance. Sonoma Pharmaceuticals' income from non-permissible sources stays below 5% of revenue in the October 2026 screening.

Does Sonoma Pharmaceuticals meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing investments currently exceed the 30% cap, measured against a market capitalisation of $6.13M (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for Sonoma Pharmaceuticals?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance